MRK

XNYS

MERCK & CO. INC.

Avg. sentiment
0.50bullish

3 news · 90d

7d trend

0 news · vs previous 7d ()

Breakdown
300
Sentiment velocity
+0.000/day

Acceleration +0.000 (vs prior 7d)

No price data available for this ticker.

Daily digest

Track $MRK sentiment without checking the page.

Top-discussed tickers and the AI sentiment we read. Not advice.

  • Jun 11 11:36▲ 0.40M&ASeekingAlpharel 60%
    Merck Animal Health to buy biodevice developer TARGAN

    Merck Animal Health, a division of Merck & Co., has announced an agreement to acquire TARGAN, a developer of biodevices for animal health applications. Financial terms of the deal were not disclosed in the headline. The acquisition expands Merck Animal Health's technology portfolio in the biodevice space.

  • Apr 24 15:06▲ 0.50Yahoorel 20%
    Alphabet Cloud AI Push And Valuation Outlook After Gemini And TPU News

    Alphabet's Google Cloud unveiled TPU 8t and 8i AI chips, the Gemini Enterprise Agent Platform, and a $750M enterprise AI adoption fund at its Cloud Next conference. The announcements include partnerships with Nvidia, Broadcom, Marvell, Merck, Salesforce, Deloitte, and Ulta Beauty. GOOGL was trading around $338.89 at the time of the article.

  • Apr 24 13:18▲ 0.60M&ASeekingAlpharel 70%
    Merck acquisition of Terns passes HSR waiting period expiration

    Merck's proposed acquisition of Terns Pharmaceuticals has cleared a key regulatory hurdle, with the Hart-Scott-Rodino (HSR) antitrust waiting period expiring without a challenge. This indicates U.S. antitrust regulators have no objection to the deal, moving it closer to completion. No revised deal terms or timeline for closing were mentioned in the article.